The University of Southampton
University of Southampton Institutional Repository

SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer

SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
The epithelial-mesenchymal transition (EMT) contributes to cancer metastasis. Two ZEB family members, ZEB1 and ZEB2(SIP1), inhibit transcription of the E-cadherin gene and induce EMT in vitro. However, their relevance to human cancer is insufficiently studied. Here, we performed a comparative study of SIP1 and ZEB1 proteins in cancer cell lines and in one form of human malignancy, carcinoma of the bladder. Whereas ZEB1 protein was expressed in all E-cadherin-negative carcinoma cell lines, being in part responsible for the high motility of bladder cancer cells, SIP1 was hardly ever detectable in carcinoma cells in culture. However, SIP1 represented an independent factor of poor prognosis (P = 0.005) in a series of bladder cancer specimens obtained from patients treated with radiotherapy. In contrast, ZEB1 was rarely expressed in tumor tissues; and E-cadherin status did not correlate with the patients' survival. SIP1 protected cells from UV- and cisplatin-induced apoptosis in vitro but had no effect on the level of DNA damage. The anti-apoptotic effect of SIP1 was independent of either cell cycle arrest or loss of cell-cell adhesion and was associated with reduced phosphorylation of ATM/ATR targets in UV-treated cells. The prognostic value of SIP1 and its role in DNA damage response establish a link between genetic instability and metastasis and suggest a potential importance for this protein as a therapeutic target. In addition, we conclude that the nature of an EMT pathway rather than the deregulation of E-cadherin per se is critical for the progression of the disease and patients' survival.
0027-8424
14884-14889
Sayan, A Emre
d1dbbcad-9c53-47c1-8b7e-1b45cc56e077
Griffiths, Thomas R.
4ff04459-73ba-4cb4-b06c-9d20083f269d
Pal, Raj
acff0c7f-e332-407f-9a4f-d1705593111e
Browne, Gareth J.
8cccea56-8e97-4208-b9d0-a7121298519e
Ruddick, Andrew
c02de191-ea67-4866-95f7-6ad7af4fdb90
Yagci, Tamer
f2e09e8c-1299-4b37-ad56-85926d20fc56
Edwards, Richard
e50ae2bd-0c64-4986-a631-275644fc6739
Mayer, Nick J.
36b41c36-1568-4cd8-8de9-c37b6a17cddd
Qazi, Hasan
7b3133ed-6f59-4131-a834-c431981ef3ab
Goyal, Sandeep
206d68a3-68db-443b-bd70-8e33676cdcf1
Fernandez, Serena
e6b907e6-ee50-49f8-ad40-f990c9aa495f
Straatman, Kees
c93bdf61-d547-47e6-b148-201a6420357a
Jones, George D.D.
fdac49ac-6bb7-4e41-9dca-94b3ae5b79c1
Bowman, Karen J.
c8bdab99-f7d5-4c4f-83e7-904ef44640a3
Colquhoun, Alexandra
caf377c6-7c24-4448-a4ad-0ef4a4df1d03
Mellon, J Kilian
71473344-f376-47c3-9bba-f2f0fbfc95f6
Kriajevska, Marina
23445c70-d191-4450-9151-c3129f99b0c9
Tulchinsky, Eugene
f0b81c60-c1cd-480b-936b-56bcd383e419
Sayan, A Emre
d1dbbcad-9c53-47c1-8b7e-1b45cc56e077
Griffiths, Thomas R.
4ff04459-73ba-4cb4-b06c-9d20083f269d
Pal, Raj
acff0c7f-e332-407f-9a4f-d1705593111e
Browne, Gareth J.
8cccea56-8e97-4208-b9d0-a7121298519e
Ruddick, Andrew
c02de191-ea67-4866-95f7-6ad7af4fdb90
Yagci, Tamer
f2e09e8c-1299-4b37-ad56-85926d20fc56
Edwards, Richard
e50ae2bd-0c64-4986-a631-275644fc6739
Mayer, Nick J.
36b41c36-1568-4cd8-8de9-c37b6a17cddd
Qazi, Hasan
7b3133ed-6f59-4131-a834-c431981ef3ab
Goyal, Sandeep
206d68a3-68db-443b-bd70-8e33676cdcf1
Fernandez, Serena
e6b907e6-ee50-49f8-ad40-f990c9aa495f
Straatman, Kees
c93bdf61-d547-47e6-b148-201a6420357a
Jones, George D.D.
fdac49ac-6bb7-4e41-9dca-94b3ae5b79c1
Bowman, Karen J.
c8bdab99-f7d5-4c4f-83e7-904ef44640a3
Colquhoun, Alexandra
caf377c6-7c24-4448-a4ad-0ef4a4df1d03
Mellon, J Kilian
71473344-f376-47c3-9bba-f2f0fbfc95f6
Kriajevska, Marina
23445c70-d191-4450-9151-c3129f99b0c9
Tulchinsky, Eugene
f0b81c60-c1cd-480b-936b-56bcd383e419

Sayan, A Emre, Griffiths, Thomas R., Pal, Raj, Browne, Gareth J., Ruddick, Andrew, Yagci, Tamer, Edwards, Richard, Mayer, Nick J., Qazi, Hasan, Goyal, Sandeep, Fernandez, Serena, Straatman, Kees, Jones, George D.D., Bowman, Karen J., Colquhoun, Alexandra, Mellon, J Kilian, Kriajevska, Marina and Tulchinsky, Eugene (2009) SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proceedings of the National Academy of Sciences of the United States of America, 106 (35), 14884-14889. (doi:10.1073/pnas.0902042106). (PMID:18485877)

Record type: Article

Abstract

The epithelial-mesenchymal transition (EMT) contributes to cancer metastasis. Two ZEB family members, ZEB1 and ZEB2(SIP1), inhibit transcription of the E-cadherin gene and induce EMT in vitro. However, their relevance to human cancer is insufficiently studied. Here, we performed a comparative study of SIP1 and ZEB1 proteins in cancer cell lines and in one form of human malignancy, carcinoma of the bladder. Whereas ZEB1 protein was expressed in all E-cadherin-negative carcinoma cell lines, being in part responsible for the high motility of bladder cancer cells, SIP1 was hardly ever detectable in carcinoma cells in culture. However, SIP1 represented an independent factor of poor prognosis (P = 0.005) in a series of bladder cancer specimens obtained from patients treated with radiotherapy. In contrast, ZEB1 was rarely expressed in tumor tissues; and E-cadherin status did not correlate with the patients' survival. SIP1 protected cells from UV- and cisplatin-induced apoptosis in vitro but had no effect on the level of DNA damage. The anti-apoptotic effect of SIP1 was independent of either cell cycle arrest or loss of cell-cell adhesion and was associated with reduced phosphorylation of ATM/ATR targets in UV-treated cells. The prognostic value of SIP1 and its role in DNA damage response establish a link between genetic instability and metastasis and suggest a potential importance for this protein as a therapeutic target. In addition, we conclude that the nature of an EMT pathway rather than the deregulation of E-cadherin per se is critical for the progression of the disease and patients' survival.

This record has no associated files available for download.

More information

Published date: 1 September 2009
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 183003
URI: http://eprints.soton.ac.uk/id/eprint/183003
ISSN: 0027-8424
PURE UUID: 7082228a-a732-47bb-823e-d6686022eda3
ORCID for A Emre Sayan: ORCID iD orcid.org/0000-0002-5291-1485

Catalogue record

Date deposited: 28 Apr 2011 13:25
Last modified: 15 Mar 2024 03:37

Export record

Altmetrics

Contributors

Author: A Emre Sayan ORCID iD
Author: Thomas R. Griffiths
Author: Raj Pal
Author: Gareth J. Browne
Author: Andrew Ruddick
Author: Tamer Yagci
Author: Richard Edwards
Author: Nick J. Mayer
Author: Hasan Qazi
Author: Sandeep Goyal
Author: Serena Fernandez
Author: Kees Straatman
Author: George D.D. Jones
Author: Karen J. Bowman
Author: Alexandra Colquhoun
Author: J Kilian Mellon
Author: Marina Kriajevska
Author: Eugene Tulchinsky

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×